Stella Pharma Statistics

Total Valuation

Stella Pharma has a market cap or net worth of JPY 13.04 billion. The enterprise value is 10.60 billion.

Market Cap	13.04B
Enterprise Value	10.60B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Stella Pharma has 34.03 million shares outstanding. The number of shares has increased by 7.76% in one year.

Current Share Class	34.03M
Shares Outstanding	34.03M
Shares Change (YoY)	+7.76%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	4.28%
Owned by Institutions (%)	9.63%
Float	20.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.56
PB Ratio	4.06
P/TBV Ratio	4.13
P/FCF Ratio	95.85
P/OCF Ratio	93.11
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-75.68
EV / Sales	11.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	77.90

Financial Position

The company has a current ratio of 13.44, with a Debt / Equity ratio of 0.24.

Current Ratio	13.44
Quick Ratio	10.05
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	5.63
Interest Coverage	-22.50

Financial Efficiency

Return on equity (ROE) is -5.02% and return on invested capital (ROIC) is -1.54%.

Return on Equity (ROE)	-5.02%
Return on Assets (ROA)	-1.22%
Return on Invested Capital (ROIC)	-1.54%
Return on Capital Employed (ROCE)	-1.79%
Revenue Per Employee	21.84M
Profits Per Employee	-3.18M
Employee Count	44
Asset Turnover	0.21
Inventory Turnover	0.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.13% in the last 52 weeks. The beta is 0.92, so Stella Pharma's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	+1.13%
50-Day Moving Average	343.10
200-Day Moving Average	454.53
Relative Strength Index (RSI)	57.40
Average Volume (20 Days)	297,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stella Pharma had revenue of JPY 961.00 million and -140.00 million in losses. Loss per share was -4.19.

Revenue	961.00M
Gross Profit	845.00M
Operating Income	-90.00M
Pretax Income	-138.00M
Net Income	-140.00M
EBITDA	-56.00M
EBIT	-90.00M
Loss Per Share	-4.19

Full Income Statement

Balance Sheet

The company has 3.21 billion in cash and 766.00 million in debt, giving a net cash position of 2.44 billion or 71.69 per share.

Cash & Cash Equivalents	3.21B
Total Debt	766.00M
Net Cash	2.44B
Net Cash Per Share	71.69
Equity (Book Value)	3.21B
Book Value Per Share	94.27
Working Capital	4.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 140.00 million and capital expenditures -4.00 million, giving a free cash flow of 136.00 million.

Operating Cash Flow	140.00M
Capital Expenditures	-4.00M
Free Cash Flow	136.00M
FCF Per Share	4.00

Full Cash Flow Statement

Margins

Gross margin is 87.93%, with operating and profit margins of -9.37% and -14.57%.

Gross Margin	87.93%
Operating Margin	-9.37%
Pretax Margin	-14.36%
Profit Margin	-14.57%
EBITDA Margin	-5.83%
EBIT Margin	-9.37%
FCF Margin	14.15%

Dividends & Yields

Stella Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.76%
Shareholder Yield	n/a
Earnings Yield	-1.07%
FCF Yield	1.04%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stella Pharma has an Altman Z-Score of 5.17.

Altman Z-Score	5.17
Piotroski F-Score	n/a